Moolec Science (MLEC) Non-Current Assets (2022 - 2025)
Moolec Science's (MLEC) quarterly Non-Current Assets came in at $173.5 million in Q2 2025, down 66.09% year-on-year from $511.6 million in Q2 2024, and up 694.61% quarter-over-quarter from $21.8 million in Q4 2024.
Moolec Science (MLEC) Non-Current Assets (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Non-Current Assets across 4 years of filings, most recently posting $173.5 million for Q2 2025.
- Non-Current Assets for Q2 2025 came in at $173.5 million, down 66.09% year-over-year; the trailing twelve-month figure through Jun 2025 was $173.5 million (down 66.09% YoY), and the FY2025 annual result was $173.5 million, down 66.09% from the prior year.
- Non-Current Assets came in at $173.5 million for Q2 2025 at Moolec Science, up from $21.8 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $511.6 million in Q2 2024 to a low of $4.6 million in Q2 2022.
- The 4-year median for Non-Current Assets is $19.3 million (2024), against an average of $75.6 million.
- Across the five-year window, Non-Current Assets soared 1960.33% in 2024 and slumped 66.09% in 2025, its largest moves.
- Moolec Science's Non-Current Assets stood at $12.7 million in 2022, then jumped by 39.45% to $17.8 million in 2023, then grew by 22.88% to $21.8 million in 2024, then soared by 694.61% to $173.5 million in 2025.
- The last three Non-Current Assets figures came in at $173.5 million (Q2 2025), $21.8 million (Q4 2024), and $21.4 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 62,953.78 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 39.71 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 173.52 Mn |
| Dec 31, 2024 | 21.84 Mn |
| Sep 30, 2024 | 21.40 Mn |
| Jun 30, 2024 | 511.63 Mn |
| Mar 31, 2024 | 19.34 Mn |
| Dec 31, 2023 | 17.77 Mn |
| Sep 30, 2023 | 19.29 Mn |
| Jun 30, 2023 | 24.83 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 12.74 Mn |
| Jun 30, 2022 | 4.61 Mn |